Stemcell, WiCell to launch hPSC services

By The Science Advisory Board staff writers

September 1, 2021 -- Stemcell Technologies and WiCell have partnered to launch human pluripotent stem cell (hPSC) characterization and banking services.

These services aim to reduce variability and improve reproducibility for various downstream applications, including disease modeling, drug discovery, toxicology screening, and regenerative medicine research. The collaboration will make it easier for pluripotent stem cell researchers to characterize new or existing cell lines and create fully characterized banks of hPSCs, according to both organizations.

Initially, the services only will be offered in the U.S.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.